Clinical and Regulatory Features of Drugs Not Initially Approved by the FDA

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|94|6|670-677

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.94, Iss.6, 2013-12, pp. : 670-677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 7, 2015-07 ,pp. : 709-715

John Wiley & Sons Inc

Access to resources Recommend Favorite

Topiramate's effects on alcohol use similar to FDA‐approved drugs

By  

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 26, Iss. 5, 2015-05 ,pp. : 3-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans

By Kaneko Yukihiro   Fukazawa Hidesuke   Ohno Hideaki   Miyazaki Yoshitsugu  

Journal of Infection and Chemotherapy, Vol. 19, Iss. 6, 2013-12 ,pp. : 1141-1145

Springer Publishing Company

Access to resources Recommend Favorite

Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: A retrospective study

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 9, 2010-09 ,pp. : 1537-1542

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Drugs Accepted by the FDA

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 12, Iss. 8, 1964-08 ,pp. : 811-811

John Wiley & Sons Inc

Access to resources Recommend Favorite